Last updated: 28 October 2019 at 5:26pm EST

Associates Iv L P Venrock H... Net Worth




The estimated Net Worth of Associates Iv L P Venrock H... is at least $782 Thousand dollars as of 24 October 2019. Associates H owns over 1,093,847 units of Bellerophon Therapeutics Inc stock worth over $257,407 and over the last 6 years Associates sold BLPH stock worth over $525,047.

Associates H BLPH stock SEC Form 4 insiders trading

Associates has made over 2 trades of the Bellerophon Therapeutics Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Associates sold 1,093,847 units of BLPH stock worth $525,047 on 24 October 2019.

The largest trade Associates's ever made was selling 1,093,847 units of Bellerophon Therapeutics Inc stock on 24 October 2019 worth over $525,047. On average, Associates trades about 618,352 units every 137 days since 2019. As of 24 October 2019 Associates still owns at least 6,435,173 units of Bellerophon Therapeutics Inc stock.

You can see the complete history of Associates H stock trades at the bottom of the page.



Insiders trading at Bellerophon Therapeutics Inc

Over the last 10 years, insiders at Bellerophon Therapeutics Inc have traded over $8,853,497 worth of Bellerophon Therapeutics Inc stock and bought 9,412,012 units worth $57,370,250 . The most active insiders traders include Robert Nelsen, Adam Weinstein, and Associates Iv L P Venrock H.... On average, Bellerophon Therapeutics Inc executives and independent directors trade stock every 61 days with the average trade being worth of $10,679. The most recent stock trade was executed by Capital Management Lp Puiss... on 13 October 2023, trading 1,076,841 units of BLPH stock currently worth $107,684.



What does Bellerophon Therapeutics Inc do?

bellerophon therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. our mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need.



What does Bellerophon Therapeutics Inc's logo look like?

Bellerophon Therapeutics Inc logo

Complete history of Associates H stock trades at Bellerophon Therapeutics Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
24 Oct 2019 Associates Iv L P Venrock H...
Sale 1,093,847 $0.48 $525,047
24 Oct 2019
6,435,173
23 Jan 2019 Associates Iv L P Venrock H...
Buy 142,857 $0.70 $100,000
23 Jan 2019
7,529,020


Bellerophon Therapeutics Inc executives and stock owners

Bellerophon Therapeutics Inc executives and other stock owners filed with the SEC include: